| US 7,538,201 B2 | ||
| Recombinant herpesvirus and uses thereof | ||
| Takashi Okuda, Tokyo (Japan); Shuji Saitoh, Tokyo (Japan); and Sakiko Saeki, Tokyo (Japan) | ||
| Assigned to Zeon Corporation, Tokyo (Japan) | ||
| Appl. No. 10/594,449 PCT Filed Mar. 09, 2005, PCT No. PCT/JP2005/004585 § 371(c)(1), (2), (4) Date Sep. 26, 2006, PCT Pub. No. WO2005/093070, PCT Pub. Date Oct. 06, 2005. |
||
| Claims priority of application No. 2004-095500 (JP), filed on Mar. 29, 2004. | ||
| Prior Publication US 2007/0212377 A1, Sep. 13, 2007 | ||
| Int. Cl. C07H 21/04 (2006.01); C12N 7/00 (2006.01) | ||
| U.S. Cl. 536—23.1 [435/235.1] | 12 Claims |
| 1. A recombinant herpesvirus that is not infectious laryngotracheitis virus, wherein the recombinant herpesvirus has a DNA that encodes the polypeptide of SEQ ID NO: 2, but that does not encode any other portion of the gB protein of infectious laryngotracheitis virus. |